Charlottesville

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Endometrial cancer2 trials
• Lung cancer1 trial
• Osteoarthritis1 trial
• Ovarian cancer1 trial

Phase

• Phase 33 trials
• Phase 11 trial
• Phase 21 trial

Status

• Active, not recruiting3 trials
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Tesaro, Inc.3 trials
• GlaxoSmithKline2 trials

Running trials

• Recruiting

  A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)

  NCT07286331· Phase 3· GlaxoSmithKline· Source

  Contact: Linda Duska (principal investigator)

• Active, not recruiting

  A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer

  NCT03981796· Phase 3· Tesaro, Inc.· Source

• Active, not recruiting

  A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer

  NCT03602859· Phase 3· Tesaro, Inc.· Source

• Active, not recruiting

  Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors

  NCT02715284· Phase 1· Tesaro, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Endometrial cancer1 recruiting

Closed trials

• Terminated

  A Dose-Finding Study to Evaluate the Efficacy and Safety of GSK3858279 in Adults With Knee Osteoarthritis (OA) Pain

  NCT05838742· Phase 2· GlaxoSmithKline· Source